WO2005042026A1 - 可逆性熱ゲル化水性組成物 - Google Patents
可逆性熱ゲル化水性組成物 Download PDFInfo
- Publication number
- WO2005042026A1 WO2005042026A1 PCT/JP2004/016500 JP2004016500W WO2005042026A1 WO 2005042026 A1 WO2005042026 A1 WO 2005042026A1 JP 2004016500 W JP2004016500 W JP 2004016500W WO 2005042026 A1 WO2005042026 A1 WO 2005042026A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aqueous composition
- reversible thermogelling
- reversible
- thermogelling aqueous
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04799523A EP1681065A4 (en) | 2003-10-31 | 2004-11-01 | WATER-BASED COMPOSITION SUBJECTED TO REVERSIBLE THERMOREGULATION |
KR1020067008092A KR101144647B1 (ko) | 2003-10-31 | 2004-11-01 | 가역성 열 겔화 수성 조성물 |
JP2005515218A JP4947977B2 (ja) | 2003-10-31 | 2004-11-01 | 可逆性熱ゲル化水性組成物 |
US11/414,498 US20060211599A1 (en) | 2003-10-31 | 2006-05-01 | Reversibly heat-gelable aqueous composition |
US13/175,394 US20110263587A1 (en) | 2003-10-31 | 2011-07-01 | Reversibly heat-gelable aqueous composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003-371572 | 2003-10-31 | ||
JP2003371572 | 2003-10-31 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/414,498 Continuation US20060211599A1 (en) | 2003-10-31 | 2006-05-01 | Reversibly heat-gelable aqueous composition |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005042026A1 true WO2005042026A1 (ja) | 2005-05-12 |
Family
ID=34543960
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/016500 WO2005042026A1 (ja) | 2003-10-31 | 2004-11-01 | 可逆性熱ゲル化水性組成物 |
Country Status (5)
Country | Link |
---|---|
US (2) | US20060211599A1 (ja) |
EP (1) | EP1681065A4 (ja) |
JP (1) | JP4947977B2 (ja) |
KR (1) | KR101144647B1 (ja) |
WO (1) | WO2005042026A1 (ja) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006004086A1 (ja) * | 2004-07-02 | 2006-01-12 | Wakamoto Pharmaceutical Co., Ltd. | アジスロマイシン含有可逆性熱ゲル化水性組成物 |
JP2008120795A (ja) * | 2006-10-18 | 2008-05-29 | Taisho Pharmaceutical Co Ltd | 粘膜適用液剤 |
WO2008100032A1 (en) * | 2007-02-15 | 2008-08-21 | Choongwae Pharma Corporation | Thixotropic pharmaceutical compositions |
WO2009001899A1 (ja) | 2007-06-26 | 2008-12-31 | Wakamoto Pharmaceutical Co., Ltd. | 水性組成物 |
JP2009515921A (ja) * | 2005-11-17 | 2009-04-16 | ウーアザファルマ アールツナイミッテル ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント カンパニー カーゲー | デクスパンテノール、カルシウムイオン、およびリン酸塩を含まない薬学的組成物、ならびにカルシウムキレート剤および眼科的に適合性の粘性調節剤の使用 |
JP2009263340A (ja) * | 2008-03-31 | 2009-11-12 | Taisho Pharmaceutical Co Ltd | 粘膜適用液剤 |
JP2010143868A (ja) * | 2008-12-19 | 2010-07-01 | Wakamoto Pharmaceut Co Ltd | 化粧料 |
JP2014512387A (ja) * | 2011-04-22 | 2014-05-22 | アルコン リサーチ, リミテッド | 二つの異なる粘性増強剤を有する粘性増強システムを備えた眼科用組成物 |
JP2016525115A (ja) * | 2013-07-17 | 2016-08-22 | ダウ グローバル テクノロジーズ エルエルシー | メチルセルロースを含む粘膜適用組成物 |
US9456980B2 (en) | 2007-08-29 | 2016-10-04 | Wakamoto Pharmaceutical Co., Ltd. | Latanoprost-containing aqueous pharmaceutical composition |
WO2018199180A1 (ja) | 2017-04-25 | 2018-11-01 | わかもと製薬株式会社 | 熱ゲル化人工涙液 |
WO2022065404A1 (ja) * | 2020-09-25 | 2022-03-31 | アステラス製薬株式会社 | 耳内投与用の医薬組成物 |
JP7336105B2 (ja) | 2017-09-14 | 2023-08-31 | 協同乳業株式会社 | 涙液分泌能・涙液安定性を改善するための飲食品または製剤 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007112272A2 (en) | 2006-03-28 | 2007-10-04 | Javelin Pharmaceuticals, Inc. | Formulations of low dose diclofenac and beta-cyclodextrin |
CN101410012A (zh) * | 2006-03-28 | 2009-04-15 | 杰佛林制药公司 | 低剂量的非甾体抗炎药和β-环糊精的制剂 |
ITMI20071120A1 (it) * | 2007-06-01 | 2008-12-02 | Apharm Srl | Composizione antiartrosica |
US11969501B2 (en) * | 2008-04-21 | 2024-04-30 | Dompé Farmaceutici S.P.A. | Auris formulations for treating otic diseases and conditions |
WO2011085424A1 (de) * | 2010-01-13 | 2011-07-21 | Georg Bischof | Zusammensetzung zur erzeugung einer temporären darmokklusion |
CN103110575B (zh) * | 2013-03-07 | 2014-11-05 | 宁夏康亚药业有限公司 | 一种美洛昔康滴眼液及其制备方法和应用 |
WO2017146853A1 (en) * | 2016-02-24 | 2017-08-31 | Dow Global Technologies Llc | Aqueous composition comprising water-soluble esterified cellulose ethers |
CN109833294B (zh) * | 2019-04-19 | 2020-06-09 | 江苏远恒药业有限公司 | 一种盐酸洛美沙星滴眼液及其制备工艺 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2729859B2 (ja) * | 1993-04-16 | 1998-03-18 | わかもと製薬株式会社 | 可逆性熱ゲル化水性医薬組成物 |
JPH10505822A (ja) * | 1994-08-25 | 1998-06-09 | エノシス・エス・エイ | 共−乾燥されたスクラルファートゲル及びポリアルコールを含む製薬学的組成物 |
WO2002011734A1 (fr) * | 2000-08-08 | 2002-02-14 | Wakamoto Pharmaceutical Co., Ltd. | Compositions pharmaceutiques aqueuses |
JP2003095924A (ja) * | 2001-07-16 | 2003-04-03 | Wakamoto Pharmaceut Co Ltd | 熱ゲル化人工涙液 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2487600A (en) * | 1945-10-09 | 1949-11-08 | Sharp & Dohme Inc | Aqueous thixotropic gel composition |
US2703777A (en) * | 1950-05-02 | 1955-03-08 | Iso Sol Company Inc | Ophthalmological preparations and vehicles and method of making the same |
GB806723A (en) * | 1955-09-02 | 1958-12-31 | Ici Ltd | New pharmaceutical compositions |
CA1218601A (en) * | 1983-09-02 | 1987-03-03 | Angel B. Casillan | Sucralfate suspension |
US5068225A (en) * | 1987-05-04 | 1991-11-26 | Mdr Group, Inc. | Viscoelastic fluid for use in surgery and other therapies and method of using same |
DE4209722C3 (de) * | 1992-03-25 | 1997-06-19 | Medproject Pharma Entwicklungs | Tropfbares Gel für die Augenheilkunde |
JP2968397B2 (ja) * | 1992-09-25 | 1999-10-25 | 信越化学工業株式会社 | 口腔用水性ゲル基剤 |
ES2121599T3 (es) * | 1993-08-30 | 1998-12-01 | Medichemie Ag | Medicamento que contiene acido ursodeoxicolico en forma de administracion liquida. |
DE69526369T2 (de) * | 1995-01-20 | 2002-11-07 | Wakamoto Pharma Co Ltd | Entzündungshemmende augentropfen |
US6432448B1 (en) * | 1999-02-08 | 2002-08-13 | Fmc Corporation | Edible coating composition |
SG98393A1 (en) * | 2000-05-19 | 2003-09-19 | Inst Materials Research & Eng | Injectable drug delivery systems with cyclodextrin-polymer based hydrogels |
US6495164B1 (en) * | 2000-05-25 | 2002-12-17 | Alkermes Controlled Therapeutics, Inc. I | Preparation of injectable suspensions having improved injectability |
JP5148787B2 (ja) * | 2001-02-08 | 2013-02-20 | サンスター株式会社 | 口腔用組成物 |
US20050234018A1 (en) * | 2004-04-15 | 2005-10-20 | Allergan, Inc. | Drug delivery to the back of the eye |
-
2004
- 2004-11-01 KR KR1020067008092A patent/KR101144647B1/ko not_active IP Right Cessation
- 2004-11-01 JP JP2005515218A patent/JP4947977B2/ja active Active
- 2004-11-01 EP EP04799523A patent/EP1681065A4/en not_active Withdrawn
- 2004-11-01 WO PCT/JP2004/016500 patent/WO2005042026A1/ja active Application Filing
-
2006
- 2006-05-01 US US11/414,498 patent/US20060211599A1/en not_active Abandoned
-
2011
- 2011-07-01 US US13/175,394 patent/US20110263587A1/en not_active Abandoned
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2729859B2 (ja) * | 1993-04-16 | 1998-03-18 | わかもと製薬株式会社 | 可逆性熱ゲル化水性医薬組成物 |
JPH10505822A (ja) * | 1994-08-25 | 1998-06-09 | エノシス・エス・エイ | 共−乾燥されたスクラルファートゲル及びポリアルコールを含む製薬学的組成物 |
WO2002011734A1 (fr) * | 2000-08-08 | 2002-02-14 | Wakamoto Pharmaceutical Co., Ltd. | Compositions pharmaceutiques aqueuses |
JP2003095924A (ja) * | 2001-07-16 | 2003-04-03 | Wakamoto Pharmaceut Co Ltd | 熱ゲル化人工涙液 |
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006004086A1 (ja) * | 2004-07-02 | 2006-01-12 | Wakamoto Pharmaceutical Co., Ltd. | アジスロマイシン含有可逆性熱ゲル化水性組成物 |
JP2009515921A (ja) * | 2005-11-17 | 2009-04-16 | ウーアザファルマ アールツナイミッテル ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント カンパニー カーゲー | デクスパンテノール、カルシウムイオン、およびリン酸塩を含まない薬学的組成物、ならびにカルシウムキレート剤および眼科的に適合性の粘性調節剤の使用 |
JP2008120795A (ja) * | 2006-10-18 | 2008-05-29 | Taisho Pharmaceutical Co Ltd | 粘膜適用液剤 |
WO2008100032A1 (en) * | 2007-02-15 | 2008-08-21 | Choongwae Pharma Corporation | Thixotropic pharmaceutical compositions |
WO2009001899A1 (ja) | 2007-06-26 | 2008-12-31 | Wakamoto Pharmaceutical Co., Ltd. | 水性組成物 |
JP5340149B2 (ja) * | 2007-06-26 | 2013-11-13 | わかもと製薬株式会社 | 水性組成物 |
US9456980B2 (en) | 2007-08-29 | 2016-10-04 | Wakamoto Pharmaceutical Co., Ltd. | Latanoprost-containing aqueous pharmaceutical composition |
JP2009263340A (ja) * | 2008-03-31 | 2009-11-12 | Taisho Pharmaceutical Co Ltd | 粘膜適用液剤 |
JP2010143868A (ja) * | 2008-12-19 | 2010-07-01 | Wakamoto Pharmaceut Co Ltd | 化粧料 |
JP2014512387A (ja) * | 2011-04-22 | 2014-05-22 | アルコン リサーチ, リミテッド | 二つの異なる粘性増強剤を有する粘性増強システムを備えた眼科用組成物 |
JP2016525115A (ja) * | 2013-07-17 | 2016-08-22 | ダウ グローバル テクノロジーズ エルエルシー | メチルセルロースを含む粘膜適用組成物 |
WO2018199180A1 (ja) | 2017-04-25 | 2018-11-01 | わかもと製薬株式会社 | 熱ゲル化人工涙液 |
KR20190110624A (ko) | 2017-04-25 | 2019-09-30 | 와카모토 세이야꾸 가부시끼가이샤 | 열겔화 인공 누액 |
US10532026B2 (en) | 2017-04-25 | 2020-01-14 | Wakamoto Pharmaceutical Co., Ltd. | Thermo-responsive gelling artificial lacrima |
KR20200020999A (ko) | 2017-04-25 | 2020-02-26 | 와카모토 세이야꾸 가부시끼가이샤 | 열겔화 인공 누액 |
US11096889B2 (en) | 2017-04-25 | 2021-08-24 | Wakamoto Pharmaceutical Co., Ltd. | Thermo-responsive gelling artificial lacrima |
JP7336105B2 (ja) | 2017-09-14 | 2023-08-31 | 協同乳業株式会社 | 涙液分泌能・涙液安定性を改善するための飲食品または製剤 |
WO2022065404A1 (ja) * | 2020-09-25 | 2022-03-31 | アステラス製薬株式会社 | 耳内投与用の医薬組成物 |
Also Published As
Publication number | Publication date |
---|---|
JPWO2005042026A1 (ja) | 2007-04-26 |
KR101144647B1 (ko) | 2012-05-08 |
JP4947977B2 (ja) | 2012-06-06 |
KR20060108628A (ko) | 2006-10-18 |
US20110263587A1 (en) | 2011-10-27 |
EP1681065A1 (en) | 2006-07-19 |
EP1681065A4 (en) | 2011-12-28 |
US20060211599A1 (en) | 2006-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005042026A1 (ja) | 可逆性熱ゲル化水性組成物 | |
EP1312366B1 (en) | Gelling aqueous pharmaceutical compositions | |
RU2108112C1 (ru) | Водная лекарственная композиция, обладающая свойством обратимого терморегулируемого гелеобразования | |
JP5340149B2 (ja) | 水性組成物 | |
JP2010037327A (ja) | ブリンゾラミド水性組成物 | |
WO2006004085A1 (ja) | アジスロマイシン含有水性医薬組成物及びその調製方法 | |
JP2016041738A (ja) | 点眼用水性組成物 | |
JP2017190348A (ja) | 水性眼科組成物 | |
WO1999063968A1 (fr) | Preparations aqueuses contenant des medicaments faiblement solubles | |
WO2015125921A1 (ja) | 保存効力を有する医薬用水性組成物 | |
JP6185725B2 (ja) | 水性医薬組成物 | |
JP4263456B2 (ja) | ヒアルロン酸含有熱ゲル化製剤 | |
TWI733019B (zh) | 熱凝膠化人工淚液 | |
JP4263418B2 (ja) | 熱ゲル化人工涙液 | |
JP2005247804A (ja) | 点眼剤 | |
WO2006004086A1 (ja) | アジスロマイシン含有可逆性熱ゲル化水性組成物 | |
JP3504656B2 (ja) | 水性医薬組成物 | |
WO2004026953A1 (ja) | 透明な可逆性熱ゲル化水性組成物 | |
TW201330851A (zh) | 用於鼻內施用唑吡坦(zolpidem)的治療組合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1020067008092 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004799523 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005515218 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11414498 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2004799523 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 11414498 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067008092 Country of ref document: KR |